Remove 2002 Remove Diabetes Remove Vaccines
article thumbnail

207 community hospital presidents and CEOs to know | 2025

Beckers Hospital Review

Hoey directed field hospital operations and oversaw a mass vaccination program that administered over 140,000 doses. She has held her position since 2002. A 28-year hospital veteran, she previously served as CNO, leading Lowell General to four Magnet recognitions. During the pandemic, Ms. In 2020, the organization recognized Ms.

article thumbnail

Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure

PharmaShots

R&D Expenditure: $883M Founded Year: 2002 Total Employees: ~2000 Headquarters: Massachusetts, United States Market Cap: $25.4B The company strives to discover and develop therapeutic products under its business segments, including General Medicines, Specialty Medicines, and Vaccines. R&D Expenditure: $3.5B

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A history of Johnson & Johnson

pharmaphorum

During this tenure, J&J entered into the areas of vision care, mechanical wound closure and diabetes management. Weldon became the Chairman and CEO of J&J in 2002. Acquisitions post-Janssen. Between 1976 and 1989, James E. Burke was chairman and CEO of J&J. billion the following February.

article thumbnail

A history of Pfizer

pharmaphorum

Others rapidly followed, including Glucotrol, aimed at diabetics, and Procardia, an anti-hypertensive. Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016. The era of mega-mergers.